Activation of the TGF-β signaling pathway promotes fibrosis in both muscle and skin tissues in DM patients, while in interstitial lung disease patients, TGF-β drives pulmonary fibroblast activation, resulting in collagen deposition and pulmonary fibrosis. The gene discussed is TGFB1; the disease is dermatomyositis.